|1.||He, Jiucheng: 2 articles (01/2006 - 04/2004)|
|2.||Bazan, Nicolas G: 2 articles (01/2006 - 04/2004)|
|3.||Bazan, Haydee E P: 2 articles (01/2006 - 04/2004)|
|4.||Esquenazi, Salomon: 1 article (04/2004)|
|1.||Wounds and Injuries (Trauma)
04/01/2004 - "The histopathological evaluation and immunohistochemical studies showed that treatment with LAU 0901 blocked keratocyte apoptosis, transformation of fibroblasts to myofibroblasts and migration to the wound site, and chemotaxis of inflammatory cells, inhibiting the inflammatory response and promoting adequate healing of the flap interface and adjacent stroma."
01/01/2006 - "Clinical Relevance The inhibition of PAF action by LAU0901 could be important in the immediate and intermediate treatment of chemical injuries to preserve the integrity of the cornea."
04/01/2004 - "Corneas not treated with LAU 0901 and controls showed a severe inflammatory response in the flap margin and stromal interface, characterized by loss of keratocytes, activation of adjacent keratocytes and transformation to myofibroblasts, infiltration of polymorphonuclear leukocytes and monocytes, and presence of epithelial cells with necrosis and melting of adjacent stroma. "